ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GNPX Genprex Inc

2.36
0.10 (4.42%)
取引時間後
最終更新日: 05:00:02
15分遅延
名称 銘柄コード 市場 種別
Genprex Inc GNPX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.10 4.42% 2.36 05:00:02
始値 安値 高値 終値 前日終値
2.34 2.2726 2.38 2.36 2.26
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0121:31PRNUSGenprex to Present and Participate at Upcoming May Investor..
2024/4/0921:31PRNUSGenprex Collaborators Report Positive Preclinical Data on..
2024/4/0321:31PRNUSGenprex Expands Clinical Trial Sites for Acclaim-3 Clinical..
2024/4/0221:31PRNUSGenprex Collaborators Publish Positive Preclinical Data with..
2024/3/2305:10PRNUSGenprex Announces Closing of $6.5 Million Registered Direct..
2024/3/2002:24PRNUSGenprex Announces $6.5 Million Registered Direct Offering..
2024/3/1921:36PRNUSGenprex Announces $6.5 Million Registered Direct Offering..
2024/3/1222:01PRNUSGenprex Receives Notice of Patent Grant for Korean Patent..
2024/3/0623:18EDGAR2Form 8-K - Current report
2024/3/0622:30PRNUSGenprex Collaborators to Present Positive Preclinical Data..
2024/2/2622:45EDGAR2Form 8-K - Current report
2024/2/2206:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1504:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0722:15PRNUSGenprex Expands Nonclinical Programs into New Therapeutic..
2024/2/0621:30PRNUSGenprex to Present at Upcoming BIO CEO & Investor Conference
2024/2/0522:15EDGAR2Form 8-K - Current report
2024/2/0521:30PRNUSGenprex Announces First Patient Dosed in Phase 2a Expansion..
2024/2/0221:30EDGAR2Form 8-K - Current report
2024/1/3123:00EDGAR2Form 8-K - Current report
2024/1/3122:42PRNUSGenprex Announces 1-for-40 Reverse Stock Split Effective..
2024/1/0606:17EDGAR2Form 8-K - Current report
2024/1/0521:00PRNUSGenprex Provides Business Update and Outlook for 2024
2023/12/1906:35EDGAR2Form 8-K - Current report
2023/12/1406:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1406:44EDGAR2Form 8-K - Current report
2023/11/1501:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0405:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/0405:16EDGAR2Form DEF 14A - Other definitive proxy statements
2023/11/0120:30PRNUSGenprex to Present at BIO-Europe 2023 Conference
2023/10/2406:01EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/10/2405:44EDGAR2Form 8-K - Current report
2023/10/2020:30PRNUSGenprex to Host a Virtual Key Opinion Leader Event on..
2023/10/0501:00PRNUSGenprex to Present Data on the Use of REQORSA® for the..
2023/9/2605:20EDGAR2Form 8-K - Current report
2023/9/2121:30GLOBEGenprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation..
2023/9/2021:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
2023/9/0905:20EDGAR2Form 8-K - Current report
2023/9/0720:30PRNUSGenprex to Present at Upcoming September Investor Conference
2023/9/0205:17EDGAR2Form 8-K - Current report
2023/8/2220:30PRNUSGenprex Appoints Suzanne Thornton-Jones as Senior Vice..
2023/8/2206:13EDGAR2Form 8-K/A - Current report: [Amend]
2023/8/2201:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1521:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2023/8/1020:30PRNUSGenprex Granted FDA Orphan Drug Designation (ODD) for..
2023/7/2501:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/7/2205:15PRNUSGenprex Announces Closing of $7.5 Million Registered Direct..
2023/7/2105:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/2005:06EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock